Norris Perne & French LLP Danaher Corp Transaction History

Norris Perne & French LLP

  • $1.3 Billion
  • Q2 2024

A detailed history of Norris Perne & French LLP transactions in Danaher Corp stock. As of the latest transaction made, Norris Perne & French LLP holds 81,086 shares of DHR stock, worth $21.9 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
81,086
Previous 78,772 2.94%
Holding current value
$21.9 Million
Previous $19.7 Million 2.99%
% of portfolio
1.56%
Previous 1.51%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024
BUY
$235.51 - $267.98 $544,970 - $620,105
2,314 Added 2.94%
81,086 $20.3 Million
Q1 2024

Apr 16, 2024
BUY
$224.58 - $256.19 $365,167 - $416,564
1,626 Added 2.11%
78,772 $19.7 Million
Q4 2023

Jan 22, 2024
BUY
$185.1 - $233.13 $250,070 - $314,958
1,351 Added 1.78%
77,146 $17.8 Million
Q3 2023

Oct 18, 2023
BUY
$233.08 - $265.59 $233,779 - $266,386
1,003 Added 1.34%
75,795 $18.8 Million
Q2 2023

Jul 19, 2023
BUY
$224.99 - $256.14 $608,372 - $692,602
2,704 Added 3.75%
74,792 $18 Million
Q1 2023

Apr 20, 2023
BUY
$239.75 - $277.0 $663,148 - $766,182
2,766 Added 3.99%
72,088 $18.2 Million
Q4 2022

Jan 24, 2023
BUY
$241.42 - $282.29 $81,358 - $95,131
337 Added 0.49%
69,322 $0
Q3 2022

Oct 13, 2022
BUY
$247.06 - $1507.4 $158,365 - $966,243
641 Added 0.94%
68,985 $17.8 Million
Q2 2022

Aug 11, 2022
BUY
$237.11 - $299.66 $384,355 - $485,748
1,621 Added 2.43%
68,344 $17.3 Million
Q1 2022

Apr 26, 2022
BUY
$257.27 - $315.76 $35,760 - $43,890
139 Added 0.21%
66,723 $19.6 Million
Q4 2021

Jan 26, 2022
SELL
$292.08 - $329.01 $36,802 - $41,455
-126 Reduced 0.19%
66,584 $21.9 Million
Q3 2021

Oct 26, 2021
BUY
$272.21 - $332.43 $85,201 - $104,050
313 Added 0.47%
66,710 $20.3 Million
Q2 2021

Jul 20, 2021
BUY
$225.08 - $271.69 $205,272 - $247,781
912 Added 1.39%
66,397 $17.8 Million
Q1 2021

Apr 30, 2021
BUY
$212.38 - $245.9 $293,084 - $339,342
1,380 Added 2.15%
65,485 $14.7 Million
Q4 2020

Jan 27, 2021
SELL
$212.5 - $245.46 $1.9 Million - $2.19 Million
-8,939 Reduced 12.24%
64,105 $14.2 Million
Q3 2020

Oct 26, 2020
SELL
$177.16 - $215.33 $29,408 - $35,744
-166 Reduced 0.23%
73,044 $15.7 Million
Q2 2020

Jul 23, 2020
SELL
$128.7 - $176.83 $1.41 Million - $1.93 Million
-10,928 Reduced 12.99%
73,210 $12.9 Million
Q1 2020

Apr 16, 2020
SELL
$121.39 - $169.05 $803,601 - $1.12 Million
-6,620 Reduced 7.29%
84,138 $11.6 Million
Q4 2019

Jan 22, 2020
BUY
$133.47 - $153.48 $1.33 Million - $1.53 Million
9,940 Added 12.3%
90,758 $13.9 Million
Q3 2019

Oct 24, 2019
BUY
$135.4 - $146.47 $36,828 - $39,839
272 Added 0.34%
80,818 $11.7 Million
Q2 2019

Jul 19, 2019
SELL
$124.88 - $143.73 $138,616 - $159,540
-1,110 Reduced 1.36%
80,546 $11.5 Million
Q1 2019

Apr 29, 2019
SELL
$97.62 - $132.29 $3.26 Million - $4.42 Million
-33,415 Reduced 29.04%
81,656 $10.8 Million
Q4 2018

Jan 28, 2019
BUY
$94.85 - $109.54 $133,359 - $154,013
1,406 Added 1.24%
115,071 $11.9 Million
Q3 2018

Oct 29, 2018
BUY
$98.13 - $108.9 $420,683 - $466,854
4,287 Added 3.92%
113,665 $12.4 Million
Q2 2018

Jul 24, 2018
BUY
$96.1 - $103.24 $251,397 - $270,075
2,616 Added 2.45%
109,378 $10.8 Million
Q1 2018

Apr 17, 2018
SELL
$92.16 - $103.8 $7,741 - $8,719
-84 Reduced 0.08%
106,762 $10.5 Million
Q4 2017

Jan 23, 2018
BUY
$85.26 - $94.62 $132,579 - $147,134
1,555 Added 1.48%
106,846 $9.92 Million
Q3 2017

Nov 01, 2017
BUY
$79.29 - $88.45 $8.35 Million - $9.31 Million
105,291
105,291 $9.03 Million

Others Institutions Holding DHR

# of Institutions
2,394
Shares Held
563M
Call Options Held
3.94M
Put Options Held
4.1M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $197B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Norris Perne & French LLP Portfolio

Follow Norris Perne & French LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email